Viewpoint
04.08.22

Closing the U.S. to Chinese Biotech Would Do Far More Harm Than Good

Scott Moore & Abigail Coplin

Biotechnology intrinsically blurs boundaries between science and commerce, market and state, the global and the national, and even personal privacy and collective interest. Progress depends more heavily in biotech than in other high-tech...

Viewpoint
03.18.20

‘This Is Not Forensic Genetics Anymore. This Is Surveillance.’

Jessica Batke

Yves Moreau, a professor specializing in human clinical genomics, had been emailing with Promega since 2016, warning its communications department first about how Promega’s products might be used in a proposed DNA databasing project in Kuwait,...

Features
02.19.20

American Company Sold DNA Analysis Equipment to Security Officials in Xinjiang, Documents Show

Jessica Batke & Mareike Ohlberg

In 2015, the Xinjiang Production and Construction Corps Public Security Bureau announced it planned to purchase equipment from the U.S.-based biotechnology company Promega for the purpose of analyzing DNA and adding it to a national database,...